NCLAT: IRP Has Authority to Take Possession of Assets Owned by Corporate Debtor  ||  NCLAT: NCLT Can Direct Forwarding a Copy of its Order to Relevant Statutory Authorities  ||  Delhi HC: Centre to Expedite Process of Accessibility Features in OTT platforms for PwDs  ||  Delhi HC: Once Worker Provides Testimony Under Oath ‘Burden of Proof’ Shifts on Employer  ||  SC: There Cannot be Discrimination in Matter of Payment of Pension to Retired Judges  ||  SC: India is Not a Dharamshala that Can Entertain Foreign Nationals from All Over  ||  SC: Can Quash Domestic Violence Act Complaints Under Section 482 of CrPC  ||  Supreme Court: Can’t Use Statement of One Accused against Another  ||  SC: Inclusion of Name in Draft NRC Cannot Annul Foreigners Tribunal’s Declaration as Non-Citizen  ||  Supreme Court: Minimum Practice of 3 Years Mandatory to Enter Judicial Service    

Search Results for Tag : trastuzumab

Judgments

Delhi High Court to delve into Drug Controller irregularities(25.04.2016)

The Delhi High Court deferred a dispute regarding the development, classification and promotion of bio-similar drugs to 2 June 2016. Brought by Roche .....

Tags : trastuzumab, bio-similar, dcgi, roche



News

Delhi High Court to Roche: Can’t Hang on to Breast Cancer Drug For Lifetime(23.02.2017)

Delhi High Court has told Swiss pharma major Roche that it “cannot hang on to” breast cancer drug Trastuzumab, innovated by it, for rest of its life a.....

Tags : Delhi High Court, Trastuzumab, Breast Cancer



Delhi HC Permits Sale and Manufacture of Breast Cancer Drug Trastuzumab(26.04.2016)

Delhi HC has allowed sale and manufacture of breast cancer drug trastuzumab by Biocon and Reliance Life Sciences, with certain restrictions.

Tags : Delhi HC, Breast Cancer Drug , Trastuzumab



Delhi HC Restrains Reliance from Launching Copy of Roche's Breast Cancer Drug(05.11.2015)

Delhi High Court has restrained Reliance Life Sciences from launching a copy of Swiss Pharma Company Roche's breast cancer drug trastuzumab.

Tags : Delhi High Court , Reliance Life Sciences, breast cancer drug trastuzumab



Disclaimer | Copyright 2025 - All Rights Reserved